Abpro Holdings, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
6 ST JOHNS LANE, FLOOR 5, NEW YORK, NY, 10013
Mailing Address
6 ST JOHNS LANE, FLOOR 5, NEW YORK, NY, 10013
Phone
248-890-7200
Fiscal Year End
1231
EIN
871013956
Financial Overview
FY2024
$4.66M
Total Assets
$19.61M
Total Liabilities
-$15.49M
Stockholders' Equity
$2.85M
Cash & Equivalents
$-0.61
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 20, 2026 | View on SEC |
| 8-K Current report of material events | February 11, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 9, 2026 | View on SEC |
| 8-K Current report of material events | February 3, 2026 | View on SEC |
| 8-K Current report of material events | January 23, 2026 | View on SEC |
| 8-K Current report of material events | January 6, 2026 | View on SEC |
| 8-K Current report of material events | December 15, 2025 | View on SEC |
| 8-K Current report of material events | December 9, 2025 | View on SEC |
| S-1/A IPO registration amendment | November 28, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
Material Events
8-K
Financial Distress
February 20, 2026
High Impact
- Abpro Holdings, Inc. is being delisted from Nasdaq.
- The delisting is due to the company's failure to meet Nasdaq's minimum stockholders' equity requirement (Rule 5550(b)(1)).
8-K
Financial Distress
December 9, 2025
High Impact
- Abpro Holdings, Inc. received an extension from Nasdaq to regain compliance with listing requirements.
- This extension prevents the company's immediate delisting from the Nasdaq exchange.
Related Companies
Companies in the same industry (SIC: 2836)
Scinai Immunotherapeutics Ltd.
SCNI
Biological Products, (No Diagnostic Substances)
Genenta Science S.p.A.
GNTA
Biological Products, (No Diagnostic Substances)
Greenland Mines Ltd
GRML
Biological Products, (No Diagnostic Substances)
Kymera Therapeutics, Inc.
KYMR
Biological Products, (No Diagnostic Substances)
Innate Pharma SA
IPHA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.